These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26743298)

  • 1. In vivo biodistribution of CNTs using a BALB/c mouse experimental model.
    Fufă MO; Mihaiescu DE; Mogoantă L; Bălşeanu TA; Mogoşanu GD; Grumezescu AM; Bolocan A
    Rom J Morphol Embryol; 2015; 56(4):1481-93. PubMed ID: 26743298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution of aqueous suspensions of carbon nanotubes in mice and their biocompatibility.
    Abe S; Itoh S; Hayashi D; Kobayashi T; Kiba T; Akasaka T; Uo M; Yawaka Y; Sato S; Watari F; Takada T
    J Nanosci Nanotechnol; 2012 Jan; 12(1):700-6. PubMed ID: 22524043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity of multiwalled carbon nanotubes with end defects critically depends on their functionalization density.
    Jain S; Thakare VS; Das M; Godugu C; Jain AK; Mathur R; Chuttani K; Mishra AK
    Chem Res Toxicol; 2011 Nov; 24(11):2028-39. PubMed ID: 21978239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and biodistribution of tyrosine modified multiwall carbon nanotubes.
    Liang G; Zhang T; Liu R; Ye B; Yin L; Pu Y
    J Nanosci Nanotechnol; 2010 Dec; 10(12):8508-15. PubMed ID: 21121360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue histology and physiology following intravenous administration of different types of functionalized multiwalled carbon nanotubes.
    Lacerda L; Ali-Boucetta H; Herrero MA; Pastorin G; Bianco A; Prato M; Kostarelos K
    Nanomedicine (Lond); 2008 Apr; 3(2):149-61. PubMed ID: 18373422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo biodistribution of platinum-based drugs encapsulated into multi-walled carbon nanotubes.
    Li J; Pant A; Chin CF; Ang WH; Ménard-Moyon C; Nayak TR; Gibson D; Ramaprabhu S; Panczyk T; Bianco A; Pastorin G
    Nanomedicine; 2014 Oct; 10(7):1465-75. PubMed ID: 24486857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon nanotube translocation to distant organs after pulmonary exposure: insights from in situ (14)C-radiolabeling and tissue radioimaging.
    Czarny B; Georgin D; Berthon F; Plastow G; Pinault M; Patriarche G; Thuleau A; L'Hermite MM; Taran F; Dive V
    ACS Nano; 2014 Jun; 8(6):5715-24. PubMed ID: 24853551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term in vivo biocompatibility of single-walled carbon nanotubes.
    Galassi TV; Antman-Passig M; Yaari Z; Jessurun J; Schwartz RE; Heller DA
    PLoS One; 2020; 15(5):e0226791. PubMed ID: 32374764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo biocompatibility testing of functionalized carbon nanotubes.
    Ciofani G; Raffa V; Vittorio O; Cuschieri A; Pizzorusso T; Costa M; Bardi G
    Methods Mol Biol; 2010; 625():67-83. PubMed ID: 20422382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo detection of magnetic labeled oxidized multi-walled carbon nanotubes by magnetic resonance imaging.
    Li R; Wu R; Zhao L; Qin H; Wu J; Zhang J; Bao R; Zou H
    Nanotechnology; 2014 Dec; 25(49):495102. PubMed ID: 25409786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current investigations into carbon nanotubes for biomedical application.
    Li X; Fan Y; Watari F
    Biomed Mater; 2010 Apr; 5(2):22001. PubMed ID: 20339169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical review of the biological mechanisms underlying the in vivo and in vitro toxicity of carbon nanotubes: The contribution of physico-chemical characteristics.
    Johnston HJ; Hutchison GR; Christensen FM; Peters S; Hankin S; Aschberger K; Stone V
    Nanotoxicology; 2010 Jun; 4(2):207-46. PubMed ID: 20795897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung deposition and toxicological responses evoked by multi-walled carbon nanotubes dispersed in a synthetic lung surfactant in the mouse.
    Ronzani C; Spiegelhalter C; Vonesch JL; Lebeau L; Pons F
    Arch Toxicol; 2012 Jan; 86(1):137-49. PubMed ID: 21805258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses of BALB/c mice to subcutaneously injected multi-walled carbon nanotubes.
    Meng J; Yang M; Jia F; Xu Z; Kong H; Xu H
    Nanotoxicology; 2011 Dec; 5(4):583-91. PubMed ID: 21034373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functionalized carbon nanotubes for anticancer drug delivery.
    Lay CL; Liu J; Liu Y
    Expert Rev Med Devices; 2011 Sep; 8(5):561-6. PubMed ID: 22026621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics Evaluation of Carbon Nanotubes Using FTIR Analysis and Histological Analysis.
    Gherman C; Tudor MC; Constantin B; Flaviu T; Stefan R; Maria B; Chira S; Braicu C; Pop L; Petric RC; Berindan-Neagoe I
    J Nanosci Nanotechnol; 2015 Apr; 15(4):2865-9. PubMed ID: 26353506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation by carbon nanotubes.
    Rybak-Smith MJ; Sim RB
    Adv Drug Deliv Rev; 2011 Sep; 63(12):1031-41. PubMed ID: 21669239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon nanotubes: biomaterial applications.
    Saito N; Usui Y; Aoki K; Narita N; Shimizu M; Hara K; Ogiwara N; Nakamura K; Ishigaki N; Kato H; Taruta S; Endo M
    Chem Soc Rev; 2009 Jul; 38(7):1897-903. PubMed ID: 19551170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of ligand tethered surface engineered carbon nanotubes.
    Mehra NK; Mishra V; Jain NK
    Biomaterials; 2014 Jan; 35(4):1267-83. PubMed ID: 24210872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interfacing carbon nanotubes with living mammalian cells and cytotoxicity issues.
    Cui HF; Vashist SK; Al-Rubeaan K; Luong JH; Sheu FS
    Chem Res Toxicol; 2010 Jul; 23(7):1131-47. PubMed ID: 20402485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.